Unilateral use of an auditory brainstem implant (using surface electrodes on the cochlear nuclei) may be considered medically necessary in patients with neurofibromatosis type 2, who are 12 years of age or older, and who are rendered deaf due to bilateral resection of neurofibromas of the auditory nerve.
An auditory brainstem implant is considered investigational for all other conditions including non-neurofibromatosis type 2 indications.
Bilateral use of an auditory brainstem implant is considered investigational.
Penetrating electrode auditory brainstem implant is considered investigational.
